Author: Minichart

us corporate news

Neumora 2025 10-K Report: Precision Neuroscience, Intellectual Property, and Business Overview

Minichart

March 30, 2026

Neumora Therapeutics 2025 Annual Report: Key Investor Insigh...

Continue Reading 0

SGX corporate News

Medi Lifestyle Limited Announces Completion of Major Shareholder Share Sale and New Controlling Shareholder’s Financial Support Commitment

Minichart

March 30, 2026

Medi Lifestyle Limited: Completion of Major Share Sale and N...

Continue Reading 0

us corporate news

SportsQuest, Inc. 2025 Annual Report: Franchise Consulting, Financials, and Business Overview

Minichart

March 30, 2026

SportsQuest, Inc. 2025 Annual Report - Detailed Investor Hig...

Continue Reading 0

SGX corporate News

Tianjin Pharmaceutical Da Ren Tang Group Update on Use and Reallocation of Placement Proceeds as of 2025

Minichart

March 30, 2026

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited...

Continue Reading 0

us corporate news

Eikon Therapeutics: Advancing Biopharmaceutical Innovation with Proprietary Technology Platform and Clinical-Stage Oncology Pipeline

Minichart

March 30, 2026

Eikon Therapeutics, Inc. 2025 Annual Report: Key Insights fo...

Continue Reading 0

us corporate news

Aura Biosciences 2025 Annual Report: Advancing Bel-sar for Ocular and Urologic Oncology with Late-Stage Clinical Development

Minichart

March 30, 2026

Aura Biosciences 2025 Annual Report: Key Financial and Strat...

Continue Reading 0

us corporate news

USA Rare Earth, Inc. 2025 Annual Report: Building a Resilient Mine-to-Magnet Supply Chain for Critical Minerals and Rare Earth Elements

Minichart

March 30, 2026

USA Rare Earth, Inc. 2025 Annual Report: Key Insights for In...

Continue Reading 0

us corporate news

Entrepreneur Universe Bright Group 2025 Annual Report: Digital Marketing Consulting in China, Regulatory Risks, and Business Overview

Minichart

March 30, 2026

Entrepreneur Universe Bright Group (EUBG) Annual Report: Key...

Continue Reading 0

us corporate news

Vor Bio Annual Report 2025: Telitacicept Global Development Strategy, Regulatory Overview, and Summary Risk Factors

Minichart

March 30, 2026

Vor Biopharma Inc. 2025 Annual Report - Key Investor Insight...

Continue Reading 0

us corporate news

Scienture Holdings, Inc. 2025 Annual Report: Key Risks, Forward-Looking Statements, and Business Overview

Minichart

March 30, 2026

Scienture Holdings, Inc. 2025 Annual Report: Key Highlights ...

Continue Reading 0